David Geffen School of Medicine, University of California-Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.
Chron Respir Dis. 2010;7(1):47-60. doi: 10.1177/1479972309348654. Epub 2009 Oct 30.
The standard of care in the treatment of chronic lung disease includes pulmonary rehabilitation (PR). While evidence of the effectiveness of PR in chronic obstructive lung disease (COPD) is robust, that for pulmonary fibrosis and other non-fibrotic restrictive lung diseases is less extensive. However, PR has been shown to improve functional exercise capacity and health-related quality of life in non-COPD patients, primarily those with interstitial lung diseases. This review examines mechanisms of exercise limitation in non-COPD patients and discusses how they might affect both the application of and outcome measures of PR. We also review the assessment of exercise performance, dyspnea, and quality of life as well as special protocols, safety considerations, and special techniques in PR as applied to patients with pulmonary fibrosis or restrictive lung disease. At present, there are no evidence-based guidelines for PR in non-COPD patients whereas PR is firmly recommended in COPD management. More research is needed to strengthen the evidence for the use of PR in non-COPD patients. Meanwhile, the available data, summarized in this review, support the inclusion of PR in the management of all patients with chronic lung disease including pulmonary fibrosis and restrictive lung disease.
在慢性肺部疾病的治疗中,标准护理包括肺康复(PR)。虽然 PR 在慢性阻塞性肺疾病(COPD)中的有效性证据确凿,但在肺纤维化和其他非纤维化性限制性肺部疾病中的证据则不那么广泛。然而,PR 已被证明可以改善非 COPD 患者的功能运动能力和与健康相关的生活质量,主要是那些患有间质性肺疾病的患者。这篇综述探讨了非 COPD 患者运动受限的机制,并讨论了这些机制如何影响 PR 的应用和结果衡量标准。我们还回顾了运动表现、呼吸困难和生活质量的评估,以及 PR 在肺纤维化或限制性肺疾病患者中的特殊方案、安全性考虑因素和特殊技术。目前,尚无针对非 COPD 患者的 PR 的循证指南,而 PR 在 COPD 管理中被强烈推荐。需要更多的研究来加强 PR 在非 COPD 患者中的应用证据。同时,本综述中总结的现有数据支持将 PR 纳入所有慢性肺部疾病患者(包括肺纤维化和限制性肺部疾病患者)的管理中。